RxDoctor Payments Data

Jason Ye, MD

Radiation Oncology · Los Angeles, CANPI 1528355047

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (39.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Novocure Inc. at 33.6% of the total. Reporting peaked in 2021 at $8,565 and has fallen 56.1% since, to $3,757 in 2025. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,935in general payments, 2019–2025

Across 97 payments — averaging $236.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$8K
  • AstraZeneca$4K
  • Icotec Medical Inc.$4K
  • Reflexion Medical, Inc.$2K
  • Medtronic$1K
  • Varian Medical Systems, Inc.$723
  • plus $3K from 14 others
$375,754in research payments, 2019–2025

Across 74 payments — averaging $5077.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure GmbH$270K
  • Merck$73K
  • Beigene, Ltd.$33K

What the payments were for

  • Consulting fees$9,02539%
  • Speaking & faculty fees$2,50011%
  • Travel & lodging$5,21723%
  • Food & beverage$6,19327%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,935 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$164,034
Medicare patients
226
Services billed
1,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →